Multiple myeloma is a plasma cell cancer that exploits monocytes and macrophages for growth and expansion16 through the production of inflammatory interleukins such as IL-6 that promote persistence of malignant plasma cells4,16 and enhance tumour progression.5 Monocytes,20 especially non-classical monocytes,16 increase in MM patients. Here, IL6 is linked to Miyoshi myopathy.